GSK Gsk Plc

TIDMGSK

RNS Number : 1726D

GlaxoSmithKline PLC

24 April 2017

The following amendment has been made to the Director/PDMR Shareholding announcement released on 19 April 2017 at 13:27 (BST) under RNS No 7391C.

Removal of the text which incorrectly reported that 13.866 Ordinary Shares had been acquired following the re-investment of dividends paid to shareholders on 13 April 2017 on released shares from the Company's 2009 Deferred Annual Bonus Plan on a post-tax basis - Matching Award.

All other details remain unchanged.

The full amended text is shown below.

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ====================================================================== 
 a)   Name                     Ms C Thomas 
===  ========================  ============================================ 
 b)   Position/status          SVP, HR 
===  ========================  ============================================ 
 c)   Initial notification/    Amendment 
       amendment 
===  ========================  ============================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  ============================================ 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 13 April 2017 on released 
                                shares from the Company's 2009 Deferred 
                                Annual Bonus Plan on a post-tax basis - 
                                Co-investment shares. 
===  ========================  ============================================ 
 c)   Price(s) and              Price(s)     Volume(s) 
       volume(s)                -----------  ------------------------------ 
                                 GBP16.4042   41.365 (Co-investment shares) 
                                -----------  ------------------------------ 
---  ------------------------  -------------------------------------------- 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
---  ------------------------  -------------------------------------------- 
 e)   Date of the transaction  2017-04-18 
---  ------------------------  -------------------------------------------- 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
---  ------------------------  -------------------------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHKMGZDKDMGNZM

(END) Dow Jones Newswires

April 24, 2017 11:52 ET (15:52 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From May 2024 to Jun 2024

Gsk (LSE:GSK)
Historical Stock Chart
From Jun 2023 to Jun 2024